IPM clocked 8328 Crs and grew at 12.9% .............................................................. Among the top 10, Lupin grew by 25.1% followed by Sun*at 21.8% & Pfizer at 17.2% ................................................................................. Among top 50 co's, 19 co's crossed the growth of IPM .......................................................................... Among the top 50, AstraZeneca has the highest growth of 36.1% followed by Bharat Serums at 34.6% & Intas at 32.6 % ...................................................................................... 25 co's showed growths more than 10% among the top 50 ......................................................................... Among the 11-20 ranked, Intas has the highest growth of 32.6% followed by Glenmark at 30.9% & USV at 21.7% .......................................................................................... Among the 21-30 ranked, MSD* has the highest growth at 30.6% followed by Wockhardt 30.2% & Novartis at 14.1% ................................................................................... Among the 31-40 ranked, AstraZeneca has the highest growth at 36.1% followed by Bharat Serums at 34.6% & JBCPL at 22.8% ............................................................................................ Among the 41-50 ranked, Wallace* has the highest growth at 17.8% followed by Win-Medicare at 9.8% & Fourrts at 9.3% ................................................................................................... Among the 51-60 ranked, Boehringer grew at 84.0% followed by Troikaa at 35.4% & Eli Lilly at 32.3% .............................................................................................. Among the 61-70 ranked Fresenius Kabi grew at 60.6% followed by RPG at by 34.3% followed by TTK at 21.6% ............................................................................... Intas moves to No 11 & Novartis to No 21, Eris to 29th , Hetero to 40th Rank in the IPM as on MAT July 2015. DRL crosses the 2000 Cr mark with the addition of UCB portfolio that had been acquired ............................................................................... Wallace enters the 400 Cr Club on MAT basis

1. PharmaTrac Overview
Jul 15

2. Dataset : PharmaTrac MAT JUL 2015 (Val in Crs)(Val in Crs)
INDUSTRY DYNAMICS: Grows at 10.4% CAGR…

3. Dataset : PharmaTrac MAT JUL 2015 (Val in Crs)(Val in Crs)
TOP CORPORATES: Macleods show highest GR of 23.4%…8 out of Top 10 grow
in double digits…

4. Dataset : PharmaTrac MAT JUL 2015 (Val in Crs)(Val in Crs)
SV- Sales Val
BV- Bonus Val
RANK MAT JUL 15
SV AV BV CORPORATE SV AV BV GR
% CONTRI
TO BONUS
BV % TO
SV
0 0 0 IPM 91230 87937 3293 14.5 100.0 3.6
1 1 6 SUN* 8199 7996 203 15.9 6.2 2.5
2 2 8 ABBOTT* 5696 5587 109 15.4 3.3 1.9
3 3 3 CIPLA 4568 4321 247 18.0 7.5 5.4
4 4 4 ZYDUS* 3782 3537 245 8.9 7.5 6.5
5 8 1 MANKIND 3237 2785 452 16.0 13.7 14.0
6 7 5 ALKEM* 3178 2971 207 12.1 6.3 6.5
7 5 16 LUPIN 3139 3093 47 17.6 1.4 1.5
8 6 23 GSK 3071 3041 30 5.4 0.9 1.0
9 9 13 PFIZER* 2735 2681 54 19.0 1.6 2.0
10 10 7 MACLEODS 2654 2485 169 23.4 5.1 6.4
BONUS CONTRIBUTION: 3.6% Bonus to Industry Turnover
 Maximum Bonus given by Mankind followed Aristo, Cipla, and Zydus*.
 Other companies which have high bonus component are Alkem*(207 Crs) and Sun* (203 Crs)

5. Dataset : PharmaTrac MAT JUL 2015 (Val in Crs)(Val in Crs)
Jul-14 Jul-15
MAT VAL MS GR CORPORATE MAT VAL MS GR
79642.4 100.00 7.3 IPM 91229.6 100.00 14.5
35009 43.96 5.6 TOP 10 40258 44.13 15.0
22320 28.03 8.7 11 - 25 25902 28.39 16.1
10705 13.44 12.6 26 - 50 12090 13.25 12.9
7149 8.98 7.4 51 - 100 8037 8.81 12.4
4459 5.60 1.5 100 + 4943 5.42 10.8
44.13
28.39
13.25
8.81
5.42
Jul-15
43.96
28.03
13.44
8.98
5.60
Jul-14
New Companies move up – Koye, Delcure, Saffron, Arianna………..

6. Dataset : PharmaTrac MAT JUL 2015 (Val in Crs)(Val in Crs)
GR
IPM SUN* ABBOTT* CIPLA ZYDUS* MANKIND ALKEM* LUPIN GSK PFIZER* MACLEODS
17.4 19.5 16.6 17.9 11.5 18.5 10.8 22.3 12.0 14.9 35.1
13.3 13.2 14.7 18.0 7.9 15.5 12.2 13.6 4.4 19.8 19.2
70
56 60 59
70
83
91
52
86 85
71
30
44 40 41
30
17
9
48
14 15
29
IPM SUN* ABBOTT* CIPLA ZYDUS* MANKIND ALKEM* LUPIN GSK PFIZER* MACLEODS
ACUTE CHRONIC
ACUTE/CHRONIC SPLIT: Chronic grows…Acute Dominates….Lupin & Macleods
have high Chronic growths….

7. Dataset : PharmaTrac MAT JUL 2015 (Val in Crs)(Val in Crs)
10003000500070009000
SUN*, 8199
CIPLA, 4568
ZYDUS*,
3782
MANKIND,
3237
ALKEM*,
3178
0 2000 4000 6000
ABBOTT*
, 5696
GSK,
3071
PFIZER*,
2735
SANOFI
INDIA,
2284
NOVARTI
S, 1193
77.56%
22.44%
INDIAN MNC
IPM GR VAL : 14.5
INDIAN/MNC SPLIT: Indian Companies dominate & are growing above
the Market…

8. Dataset : PharmaTrac MAT JUL 2015 (Val in Crs)(Val in Crs)
* Abbott + Abbott HC + Novo; Alkem + Indchemie + Cachet; Pfizer + Wyeth; Zydus + Biochem; Micro + Bal
MAT VAL JUL 15
ZONE MAT VAL MS MS (G / L) GR INCRE VAL
IPM 91230 100.00% 0.00% 14.5 11587
SOUTH ZONE 24512 26.87% -0.14% 13.9 2998
NORTH ZONE 23548 25.81% -0.20% 13.7 2831
WEST ZONE 21132 23.16% 0.01% 14.6 2691
EAST ZONE 18484 20.26% 0.20% 15.7 2508
ALL INDIA ONLY 3555 3.90% 0.14% 18.7 559
28.1%
27.0%
24.1%
20.8%
Jul-14
28.0%
26.9%
24.1%
21.1%
Jul-15
ZONAL SPLIT: South dominates…East grows fast…

9. Dataset : PharmaTrac MAT JUL 2015 (Val in Crs)(Val in Crs)
MAT VAL JUL 15 MS
SUPERGROUP SV BV GR INCRE VAL BV % TO SV SV BV
IPM 91230 3293 14.5 11587 3.6 100.00 100.00
ANTI-INFECTIVES 14152 1100 10.4 1329 7.8 15.51 33.42
CARDIAC 11393 95 14.9 1478 0.8 12.49 2.88
GASTRO INTESTINAL 10592 371 16.5 1502 3.5 11.61 11.26
VITAMINS / MINERALS / NUTRIENTS 8245 189 13.8 998 2.3 9.04 5.72
ANTI DIABETIC 7244 45 26.2 1504 0.6 7.94 1.37
RESPIRATORY 7136 260 15.5 959 3.6 7.82 7.90
PAIN / ANALGESICS 6323 236 12.4 696 3.7 6.93 7.17
NEURO / CNS 5568 45 12.9 637 0.8 6.10 1.36
DERMA 5364 126 18.3 831 2.3 5.88 3.83
GYNAECOLOGICAL 4504 375 9.8 402 8.3 4.94 11.38
Anti-diabetic and GI fight out………

10. Dataset : PharmaTrac MAT JUL 2015 (Val in Crs)(Val in Crs)
RANK Jul-15
BRAND SUBGROUP CORPORATE SV AV BV GR INCRE
IPM 91230 87937 3293 14.5 11587
1 0 MIXTARD HUMAN PREMIX ABBOTT* 444 442 2 26.3 92
2 0 AUGMENTIN AMOXYCILLIN + CLAVULANIC ACID GSK 331 330 0.4 29.9 76
3 1 GLYCOMET GP GLIMEPIRIDE + METFORMIN USV 312 311 1 24.1 60
4 2 MONOCEF CEFTRIAXONE ARISTO 279 194 86 23.3 53
5 0 BECOSULES VITAMIN B COMPLEX WITH VITAMIN C ONLY PFIZER* 259 252 6 13.8 31
6 1 COREX CHLORPHENIRAMINE + CODEINE PFIZER* 253 252 1 14.2 32
7 4 LANTUS GLARGINE SANOFI INDIA 240 239 1 32.0 58
8 12 PHENSEDYL COUGH LINCTUS CHLORPHENIRAMINE + CODEINE ABBOTT* 228 228 0.1 49.5 76
9 24 SPASMO PROXYVON PLUS DICYCLOMINE + PARACETAMOL + TRAMADOL WOCKHARDT 228 227 0.2 68.0 92
10 72 JANUMET SITAGLIPTIN + METFORMIN MSD* 225 223 2 138.6 131
11 -2 CLAVAM AMOXYCILLIN + CLAVULANIC ACID ALKEM* 223 190 33 3.7 8
12 -4 VOLINI DICLOFENAC SUN* 210 189 21 -4.6 -10
13 -3 DEXORANGE FERROUS COMBINATION FRANCO 210 198 12 13.8 25
14 3 GALVUS MET VILDAGLIPTIN + METFORMIN NOVARTIS 207 205 2 33.0 51
15 -1 BETADINE POVIDONE IODINE WIN-MEDICARE 192 186 7 13.2 22
16 2 SKINLITE HYDROQUINONE + MOMETASONE + TRETINOIN ZYDUS* 190 180 10 23.1 36
17 44 SHELCAL CALCIUM CARBONATE + VIT D3 TORRENT 188 175 13 77.0 82
18 4 TAXIM CEFOTAXIME ALKEM* 187 170 16 23.8 36
19 -7 MANFORCE SILDENAFIL MANKIND 185 52 133 4.4 8
20 -7 LIV 52 HEPATIC PROTECTORS INCLUDING AYURVEDIC HIMALAYA 185 185 1 6.1 11
TOP 20 BRANDS: Mixtard rules… Janumet shows highest GR and incre
Val.. Shelcal moves up fast…..

11. Dataset : PharmaTrac MAT JUL 2015 (Val in Crs)(Val in Crs)
5203 Brands launched in last 24 months…
Jul-15
BRAND SUBGROUP COMPANY LD MAT VAL INCRE VAL
NI BRANDS(LAST 24 MONTHS) 3002 2298
BIOVAC V VARICELLA VACCINE WOCKHARDT Dec-14 57 57
TRESIBA DEGLUDEC NOVO Oct-13 38 21
REVITAL H MULTIVITAMINS + MINERALS SUN* Apr-15 29 29
MOX CV AMOXYCILLIN + CLAVULANIC ACID SUN* Jan-14 27 20
HYOCIMAX HYOSCINE ZYDUS* Jan-14 24 11
TRAJENTA DUO LINAGLIPTIN + METFORMIN BOEHRINGER INGELHEIM Jan-14 23 21
HEALTH OK MULTIVITAMINS + MINERALS MANKIND Aug-13 23 14
DULCOFLEX BISACODYL BOEHRINGER INGELHEIM Jan-14 21 18
DOXT SL DOXYCYCLINE + LACTOBACILLUS DR. REDDYS Jun-14 19 18
GERBISA BISACODYL ZYDUS* Jan-14 18 5
FERINJECT IRON FERRIC LUPIN Feb-14 18 13
MEROBAX MEROPENEM ARISTO Dec-13 18 12
LIPAGLYN SAROGLITAZAR ZYDUS* Sep-13 16 10
CANMAB TRASTUZUMAB BIOCON Feb-14 16 14
LUMIA VITAMIN D3 (CHOLECALCIFEROL) SUN* May-14 16 15
REJUNEX-CD3 MULTIVITAMINS + MINERALS INTAS Jul-14 16 16
MELBILD DECA PEPTIDE + ISOPROPYL ALCOHOL + MYRISTATE + GLYCOL ALKEM* Apr-14 15 10
WOMENOX ENOXAPARIN INTAS Sep-13 15 12
PEGVIR PEGYLATED INTERFERON ALPHA 2B CIPLA Sep-13 14 10
RYZODEG INSULIN DEGLUDEC + INSULIN ASPART NOVO Dec-14 14 14

12. (Val in Crs)Dataset : PharmaTrac MAT JAN 2015